AHA to HRSA Re: 340B Civil Monetary Penalty Rule Delay

AHA comments on the Health Resources and Services Administrations interim final rule that would further delay the effective date for the implementation of the Affordable Care Act provision requiring a 340B Drug Pricing Program ceiling price calculation methodology and application of civil monetary penalties for violations of the ceiling price.

Related Resources

Letter/Comment
The AHA and five other health care organizations sent the attached letter to HHS Secretary Becerra urging him to stop the actions of six drug companies that…
Letter/Comment
Public
AHA urges the Department of Health and Human Services (HHS) to ensure hospitals currently participating in the 340B Drug Pricing Program continue to have…
Letter/Comment
Public
AHA letter to Senators, John Thune, Rob Portman, Shelley Moore Capito, Tammy Baldwin, Debbie Stabenow and Ben Cardin expressing support for legislation, S. 773.
Fact Sheets
Public
For more than 25 years, the 340B Drug Pricing Program has provided financial help to hospitals serving vulnerable communities to manage rising prescription…
Fact Sheets
Public
For nearly 30 years, the 340B Drug Pricing Program has provided financial help to safety-net hospitals to manage rising prescription drug costs. Section 340B…
Special Bulletin
Public
At A Glance The Health Resources and Services Administration (HRSA) Dec. 10 released its long-awaited final rule implementing an Affordable Care Act (ACA)…